The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
From - Laboratory Industry Report Qiagen was the most active firm of the period with a trio of new product launches, including the US launch of… . . . read more
Qiagen was the most active firm of the period with a trio of new product launches, including the US launch of Therascreen FGFR RGQ RT-PCR Kit as a companion diagnostic for Janssen Pharmaceutical’s metastatic bladder cancer drug erdafitinib following FDA approval of the test. Among the more notable launches was GenePrism:Actionable Insights, the result of a collaboration between PerkinElmer and Helix. The firms touted the new genetic screening test enabling users to assess their risk for underlying diseases as “the most comprehensive clinical grade DNA sequencing and interpretation” test currently on the market.”
Here’s a summary of all the key product launches from late March to mid-April 2019:
NEWLY LAUNCHED PRODUCTS & SERVICES | ||
Company(ies) | Product(s)/Service(s) | |
PerkinElmer and Helix | GenePrism:Actionable Insights, a genetic screening test | |
Fluidigm | Maxpar Direct Immune Profiling System for rapidly quantifying 37 different immune cell populations from human peripheral blood mononuclear cells and whole blood | |
Ares Genetics (Curetis subsidiary) |
NGS service based on its AresUPA Universal Pathogenome Assay to launch later this year | |
Qiagen | US launch of Therascreen FGFR RGQ RT-PCR Kit as companion diagnostic for Janssen Pharmaceutical’s metastatic bladder cancer drug erdafitinib (Balversa) to run on Qiagen’s Rotor-Gene Q MDx | |
Qiagen | exoRNeasy Midi and Maxi Kits for isolating exosomes and other extracellular vesicles from urine and other samples | |
Qiagen | miRNeasy 96 Advanced QiaCube HT Kit for automated purification of total RNA, including miRNA, from serum and plasma samples | |
Centogene | CentoMetabolic panel, a first-line test for rare genetic metabolic diseases | |
PetaGene | PetaSuite Protect encryption and access-management system for genomic data | |
Enpicom | IGX, short for ImmunoGenomiX immune sequencing data analysis platform | |
Quantabio | Qscript lyo 1-step, lyophilized single-reaction reagent for highly sensitive and reproducible RT-qPCR RNA uses | |
Fabric Genomics | Fabric Hereditary Panels with ACE (AI Classification Engine) software for variant interpretation and clinical reporting | |
Emedgene | Addition of automated evidence retrieval to its genetic interpretation platform | |
Progenity | Resura prenatal test for monogenic disease, a customizable, noninvasive prenatal test (NIPT) for single-gene disorders | |
Agilent Technologies | 4150 TapeStation system for analyzing quality of RNA and DNA samples | |
BGI Americas | Oseq Hereditary Cancer Panel (HGP), assay that to identify tumor biomarkers for 17 cancer types and support clinical trials of anti-cancer drugs | |
Canopy Biosciences | RareSeq error corrected sequencing service | |
GenScript | New single-stranded DNA (ssDNA) service giving researchers access to its ssDNA for CRISPR-based gene insertion | |
Congenica | On-premises installation option for its Sapientia genome analysis platform that was previously available only as a cloud product | |
RareCyte | CyteFinder II and CyteFinder II HT instruments, next-generation versions of its CyteFinder instruments for multi-omic liquid biopsy and tissue research | |
BC Platforms | Incorporation of ontology browser and data visualization dashboard to its BC Insight data management platform | |
HTG Molecular Diagnostics | HTG EdgeSeq Mouse mRNA Tumor Response Panel |
Subscribe to view Essential
Start a Free Trial for immediate access to this article